Vigneswaran, N. & Williams, M. D. Epidemiologic trends in head and neck cancer and aids in diagnosis. Oral Maxillofac. Surg. Clin. 26, 123–141 (2014).
Ng, J. H., Iyer, N. G., Tan, M.-H. & Edgren, G. Changing epidemiology of oral squamous cell carcinoma of the tongue: a global study. Head Neck 39, 297–304 (2017).
Mody, M. D., Rocco, J. W., Yom, S. S., Haddad, R. I. & Saba, N. F. Head and neck cancer. Lancet 398, 2289–2299 (2021).
Romano, A. et al. Noninvasive imaging methods to improve the diagnosis of oral carcinoma and its precursors: state of the art and proposal of a three-step diagnostic process. Cancers 13, 2864 (2021).
Article PubMed PubMed Central Google Scholar
Safi, A.-F. et al. Clinicopathological parameters affecting nodal yields in patients with oral squamous cell carcinoma receiving selective neck dissection. J. Cranio-Maxillofac. Surg. 45, 2092–2096 (2017).
Linsen, S. S., Gellrich, N.-C. & Krüskemper, G. Age-and localization-dependent functional and psychosocial impairments and health related quality of life six months after OSCC therapy. Oral Oncol. 81, 61–68 (2018).
Meier, J. K. et al. Health-related quality of life: a retrospective study on local vs. microvascular reconstruction in patients with oral cancer. BMC Oral Health 19, 1–8 (2019).
Maymone, M. B. C. et al. Premalignant and malignant oral mucosal lesions: Clinical and pathological findings. J. Am. Acad. Dermatol. 81, 59–71 (2019).
Odell, E., Kujan, O., Warnakulasuriya, S. & Sloan, P. Oral epithelial dysplasia: recognition, grading and clinical significance. Oral Dis. 27, 1947–1976 (2021).
Brandizzi, D., Gandolfo, M., Velazco, M. L., Cabrini, R. L. & Lanfranchi, H. Clinical features and evolution of oral cancer: a study of 274 cases in Buenos Aires, Argentina. Med. Oral Patol. Oral Cir. Bucal. 13, E544-8 (2008).
Bagan, J., Sarrion, G. & Jimenez, Y. Oral cancer: clinical features. Oral Oncol. 46, 414–417 (2010).
Scully, C. & Bagan, J. V. Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. Oral Dis. 15, 388–399 (2009).
Harada, H. et al. Characteristics of oral squamous cell carcinoma focusing on cases unaffected by smoking and drinking: a multicenter retrospective study. Head Neck 45, 1812–1822 (2023).
Omura, K. Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma. Int. J. Clin. Oncol. 19, 423–430 (2014).
Jerjes, W. et al. Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients. Head Neck Oncol. 2, 1–21 (2010).
Warnakulasuriya, S. Oral potentially malignant disorders: A comprehensive review on clinical aspects and management. Oral Oncol. 102, 104550 (2020).
Yap, T. et al. Non-invasive screening of a microRNA-based dysregulation signature in oral cancer and oral potentially malignant disorders. Oral Oncol. 96, 113–120 (2019).
Chuang, S.-L. et al. Malignant transformation to oral cancer by subtype of oral potentially malignant disorder: a prospective cohort study of Taiwanese nationwide oral cancer screening program. Oral Oncol. 87, 58–63 (2018).
Warnakulasuriya, S. Clinical features and presentation of oral potentially malignant disorders. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 125, 582–590 (2018).
Dionne, K. R., Warnakulasuriya, S., Binti Zain, R. & Cheong, S. C. Potentially malignant disorders of the oral cavity: Current practice and future directions in the clinic and laboratory. Int. J. Cancer 136, 503–515 (2015).
Tarakji, B. Dentists’ perception of oral potentially malignant disorders. Int. Dent. J. 72, 414–419 (2022).
Article PubMed PubMed Central Google Scholar
Kerr, A. R. & Lodi, G. Management of oral potentially malignant disorders. Oral Dis. 27, 2008–2025 (2021).
Mello, F. W. et al. Prevalence of oral potentially malignant disorders: a systematic review and meta‐analysis. J. Oral Pathol. Med. 47, 633–640 (2018).
Warnakulasuriya, S., Johnson, N. W. & van der Waal, I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J. Oral Pathol. Med. 36, 575–580 (2007).
Villa, A. & Sonis, S. Oral leukoplakia remains a challenging condition. Oral Dis. 24, 179–183 (2018).
Holmstrup, P. & Dabelsteen, E. Oral leukoplakia—to treat or not to treat. Oral Dis. 22, 494–497 (2016).
Carrard, V. C. & van der Waal, I. A clinical diagnosis of oral leukoplakia; A guide for dentists. Med. Oral Patol. Oral Cir. Bucal 23, e59 (2018).
Warnakulasuriya, S. et al. Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 27, 1862–1880 (2021).
Speight, P. M., Khurram, S. A. & Kujan, O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 125, 612–627 (2018).
Pentenero, M., Meleti, M., Vescovi, P. & Gandolfo, S. Oral proliferative verrucous leucoplakia: are there particular features for such an ambiguous entity? A systematic review. Br. J. Dermatol. 170, 1039–1047 (2014).
Cabay, R. J., Morton, T. H. Jr & Epstein, J. B. Proliferative verrucous leukoplakia and its progression to oral carcinoma: a review of the literature. J. Oral Pathol. Med. 36, 255–261 (2007).
Yang, S.-W., Lee, Y.-S., Chang, L.-C., Hsieh, T.-Y. & Chen, T.-A. Outcome of excision of oral erythroplakia. Br. J. Oral Maxillofac. Surg. 53, 142–147 (2015).
Boy, S. C. Leukoplakia and erythroplakia of the oral mucosa—a brief overview. SADJ 67, 558–560 (2012).
Holmstrup, P. Oral erythroplakia—what is it? Oral Dis. 24, 138–143 (2018).
Yang, S.-W. et al. Clinical characteristics of narrow-band imaging of oral erythroplakia and its correlation with pathology. BMC Cancer 15, 1–8 (2015).
Boy, S. C. Leukoplakia and erythroplakia of the oral mucosa-a brief overview: clinical review. SADJ 67, 558–560 (2012).
Tilakaratne, W. M., Ekanayaka, R. P. & Warnakulasuriya, S. Oral submucous fibrosis: a historical perspective and a review on etiology and pathogenesis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 122, 178–191 (2016).
Qin, X., Ning, Y., Zhou, L. & Zhu, Y. Oral submucous fibrosis: etiological mechanism, malignant transformation, therapeutic approaches and targets. Int. J. Mol. Sci. 24, 4992 (2023).
Article PubMed PubMed Central Google Scholar
Shen, Y.-W., Shih, Y.-H., Fuh, L.-J. & Shieh, T.-M. Oral submucous fibrosis: a review on biomarkers, pathogenic mechanisms, and treatments. Int. J. Mol. Sci. 21, 7231 (2020).
Article PubMed PubMed Central Google Scholar
Peng, Q., Li, H., Chen, J., Wang, Y. & Tang, Z. Oral submucous fibrosis in Asian countries. J. Oral Pathol. Med. 49, 294–304 (2020).
Al‐Hassiny, A. et al. Upregulation of angiogenesis in oral lichen planus. J. Oral Pathol. Med. 47, 173–178 (2018).
De Rossi, S. S. & Ciarrocca, K. Oral lichen planus and lichenoid mucositis. Dent. Clin. 58, 299–313 (2014).
Aghbari, S. M. H. et al. Malignant transformation of oral lichen planus and oral lichenoid lesions: a meta-analysis of 20095 patient data. Oral Oncol. 68, 92–102 (2017).
González‐Moles, M. Á. et al. Worldwide prevalence of oral lichen planus: a systematic review and meta‐analysis. Oral Dis. 27, 813–828 (2021).
Nogueira, P. A., Carneiro, S. & Ramos‐e‐Silva, M. Oral lichen planus: an update on its pathogenesis. Int. J. Dermatol. 54, 1005–1010 (2015).
Ahmadi, N. et al. Association of PD-L1 expression in oral squamous cell carcinoma with smoking, sex, and p53 expression. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 128, 631–638 (2019).
Comments (0)